Product Information
BISOPROLOL FUMARATE 10 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1603 per EA under NDC 64980071001. Its NADAC has been published 36 times since Jan 28, 2026.
FDA first approved this application on Apr 16, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980071001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISOPROLOL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA219044FDA Approved
4/16/2025
TE Code
AB
On Market Since
7/11/2025
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL FUMARATE 10 MG TAB has been published 36 times since Jan 28, 2026, and over the history we have for it it has declined 26.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1603 per EA |
|---|---|
| All-time high | $0.2166 (Feb 11, 2026) |
| All-time low | $0.1603 (Sep 23, 2026) |
| 52-week high | $0.2166 |
| 52-week low | $0.1603 |
| Median price | $0.1964 |
| Average price | $0.1940 |
| Largest weekly change | -10.2% (Sep 23, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisoprolol Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISOPROLOL FUMARATE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL FUMARATE 10 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1603 per EA (NDC 64980071001), effective Sep 30, 2026.
How has the price of BISOPROLOL FUMARATE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL FUMARATE 10 MG TAB has declined 26.0%. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for BISOPROLOL FUMARATE 10 MG TAB?
Since Jan 28, 2026, the NADAC for BISOPROLOL FUMARATE 10 MG TAB has ranged from a low of $0.1603 (Sep 23, 2026) to a high of $0.2166 (Feb 11, 2026), with a median of $0.1964 per EA.
Are there cheaper alternatives to BISOPROLOL FUMARATE 10 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL FUMARATE 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BISOPROLOL FUMARATE 10 MG TAB?
BISOPROLOL FUMARATE 10 MG TAB (NDC 64980071001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.